atai Life Sciences (ATAI) announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board subject to applicable legal requirements. Scott Braunstein, M.D., is the Chief Executive Officer and Chairman of Marinus Pharmaceuticals (MRNS). Laurent Fischer, M.D., is the CEO and President of Adverum Biotechnologies and serves on the Board of Directors at Mirum Pharmaceuticals (MIRM).
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATAI:
- Here’s What You Missed in Cannabis, Psychedelics This Week
- ATAI Life Sciences Announces CEO Transition and Compensation Terms
- atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
- Atai Life Sciences promotes Srinivas Rao to Co-EO
- Atai Life Sciences reports Q1 EPS (17c), consensus (18c)